FIGURE 2.

A comparison between preoperative oncologic therapy and upfront surgery patients in cumulative incidence for venous thromboembolism after surgery. (A) Aalen–Johansen analysis describing the statistically higher cumulative incidence rate of venous thromboembolism after surgery in preoperative oncologic therapy patients. Overall survival served as a competing event for venous thromboembolism. (B) A comparison of the cumulative incidence rate of venous thromboembolism between preoperative oncologic therapy and upfront surgery patients 1–3 years after surgery and overall VTE = venous thromboembolic event, OS = overall survival